Azithromycin in bronchiectasis: evidence in children?

Affiliations

Comment

Diana Bilton. Lancet Respir Med. 2013 Oct.

. 2013 Oct;1(8):587-589.

doi: 10.1016/S2213-2600(13)70195-4. Epub 2013 Sep 17.

¹ Royal Brompton Hospital, Department of Respiratory Medicine, London SW3 6NP, UK. Electronic address: d.bilton@rbht.nhs.uk.

No abstract available

Comment on

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB. Valery PC, et al. Lancet Respir Med. 2013 Oct;1(8):610-620. doi: 10.1016/S2213-2600(13)70185-1. Epub 2013 Sep 17. Lancet Respir Med. 2013. PMID: 24461664 Clinical Trial.